Irbesartan Zentiva (Irbesartan)

Irbesartan blocks angiotensin II type 1 (AT1) receptors, which prevents the hormone angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release. This leads to vasodilation, lower blood pressure, and reduced stress on the kidneys.

The appropriate dose of Irbesartan Zentiva is determined by the prescribing healthcare professional based on the patient’s blood pressure, kidney function, and overall health status. Patients should follow the exact regimen provided by their prescriber.

Irbesartan is classified as contraindicated in pregnancy because it may harm the developing fetus. Safety during breastfeeding has not been established, so the drug should be avoided unless the benefits clearly outweigh the risks and a physician advises otherwise.

To order Irbesartan Zentiva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers, ARBs primarily target the renin‑angiotensin system, providing additional renal protective benefits in diabetic patients.

Irbesartan Zentiva tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the medication out of reach of children and do not use after the expiration date.

Irbesartan Zentiva is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

The most serious risks include angioedema, which can cause swelling of the face or throat and impair breathing, severe hyperkalemia that may affect heart rhythm, and acute renal failure, especially when combined with other drugs that affect kidney function.

Irbesartan should not be used by individuals with known hypersensitivity to irbesartan or any ARB components, pregnant women, or patients with severe hepatic impairment. Caution is also advised for those with existing kidney disease or elevated potassium levels.